Research Article
Characteristics of Clinical Shiga Toxin-Producing Escherichia coli Isolated from British Columbia
Table 3
Antimicrobial resistance (AMR) amongst Shiga toxin-producing E. coli.
| Antimicrobial agents | STEC AMR susceptibility (%) | % AMR | Susceptible | Reduced susceptibility | Resistant | Non-O157 STEC | O157 STEC |
| Aminoglycosides | | | | | | Amikacin | 100 | 0 | 0 | 0 | 0 | Gentamicin | 100 | 0 | 0 | 0 | 0 | Kanamycin | 84 | 12 | 4 | 7 | 0 | Neomycin | 0 | 76 | 24 | 27 | 20 | Streptomycin | 72 | 8 | 20 | 20 | 20 | Penicillin | | | | | | Ampicillin | 92 | 4 | 4 | 0 | 10 | Carbapenem | | | | | | Imipenem | 100 | 0 | 0 | 0 | 0 | Cephalosporin | | | | | | Ceftazidime | 96 | 0 | 4 | 0 | 10 | Macrolide | | | | | | Erythromycin | 0 | 0 | 100 | 100 | 100 | Quinolones | | | | | | Ciprofloxacin | 100 | 0 | 0 | 0 | 0 | Nalidixic acid | 100 | 0 | 0 | 0 | 0 | Phenicol | | | | | | Chloramphenicol | 92 | 0 | 8 | 0 | 20 | Ansamycin | | | | | | Rifampicin | 100 | 0 | 0 | 100 | 100 | Spectinomycin | | | | | | Spectinomycin | 44 | 48 | 8 | 13 | 0 | Tetracylines | | | | | | Tetracycline | 64 | 20 | 16 | 13 | 20 | Sulfonamide | | | | | | Trimethoprim | 100 | 0 | 0 | 0 | 0 |
|
|